These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 6205495)

  • 1. Clinical evaluation of renovascular hypertension and therapeutic decisions.
    Vaughan ED; Case DB; Pickering TG; Sosa RE; Sos TA; Laragh JH
    Urol Clin North Am; 1984 Aug; 11(3):393-407. PubMed ID: 6205495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of captopril in the diagnostic work-up of renovascular hypertension.
    Derkx FH; Tan-Tjiong LH; Wenting GJ; Man in 't Veld A; Schalekamp MA
    J Hypertens Suppl; 1985 Dec; 3(3):S287-9. PubMed ID: 2856719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of saralasin in the recognition of angiotensinogenic hypertension.
    Streeten DH; Dalakos TG; Anderson GH
    Prog Biochem Pharmacol; 1976; 12():214-26. PubMed ID: 1019165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Saralasin test, renal vein renin and unilateral kidney blood flow in renovascular hypertension].
    Helber A; Hummerich W; Bönner G; Meurer KA; Moritz G
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():208-9. PubMed ID: 613575
    [No Abstract]   [Full Text] [Related]  

  • 5. [Saralasin and prediction of the surgical result in renovascular arterial hypertension].
    Mimran A; Deschodt G; Fourcade J; Barjon P
    Arch Mal Coeur Vaiss; 1979 Nov; 72 Spec no():16-21. PubMed ID: 119507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension, the adrenal and the kidney: lessons from pharmacologic interruption of the renin-angiotensin system.
    Hollenberg NK; Williams GH
    Adv Intern Med; 1980; 25():327-61. PubMed ID: 6153859
    [No Abstract]   [Full Text] [Related]  

  • 7. [Renovascular hypertension: prediction of surgical treatment by angiotensin II blockade and saralasin (author's transl)].
    Mimran A; Deschodt G; Barjon P; Mary H; Thevenet A
    Nouv Presse Med; 1978 Dec; 7(43):3889-93. PubMed ID: 733540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
    Zawada ET; Stinson J; Ramirez G
    Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of captopril on renal vein plasma renin ratio--diagnosis and predicting response to surgery in renovascular hypertension].
    Takata M; Sugimoto T; Mikawa M; Yoshida K; Iuchi K; Iida H; Mizumura Y; Nakada T; Kawahara Y
    Nihon Jinzo Gakkai Shi; 1983 Aug; 25(8):1017-26. PubMed ID: 6366302
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renovascular hypertension. Predictability of surgical cure of unilateral renal artery stenosis and bilateral renal artery stenosis.
    Rosenthal JT; Libertino JA
    Eur Urol; 1982; 8(2):88-93. PubMed ID: 7037421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saralasin infusion in renovascular and essential hypertension.
    Thien T; Hoefnagels WH
    Neth J Med; 1980; 23(2):68-73. PubMed ID: 6990282
    [No Abstract]   [Full Text] [Related]  

  • 13. Laboratory tests in the evaluation of renal hypertension.
    Vaughan ED
    Urol Clin North Am; 1979 Oct; 6(3):485-502. PubMed ID: 388789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of saralasin on blood pressure, renin and renal blood flow in unilateral renovascular hypertension.
    Arlart IP; Rosenthal J; Wagner H; Adam WE; Nobbe F; Franz HE
    Contrib Nephrol; 1978; 11():170-4. PubMed ID: 699587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic probes to identify patients with renovascular hypertension.
    Sosa RE; Vaughan ED
    Semin Urol; 1985 Nov; 3(4):317-24. PubMed ID: 2887024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grand rounds: diagnosis and management of renovascular hypertension.
    Carey RM
    Va Med; 1979 Nov; 106(11):809-18. PubMed ID: 388907
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of saralasin in end-stage renal disease.
    Fadem SZ; Lifschitz MD
    Kidney Int Suppl; 1979 Mar; (9):S93-100. PubMed ID: 289869
    [No Abstract]   [Full Text] [Related]  

  • 18. [Renovascular arterial hypertension: current aspects of physiopathology, diagnosis and treatment].
    Humke U; Ziegler M
    Ann Urol (Paris); 1997; 31(2):64-76. PubMed ID: 9245250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacologic functional examination in arterial hypertension].
    Stumpe KO; Kolloch R; Overlack A
    Internist (Berl); 1977 Nov; 18(11):594-600. PubMed ID: 23361
    [No Abstract]   [Full Text] [Related]  

  • 20. Prospective analysis of strategies for diagnosing renovascular hypertension.
    Svetkey LP; Himmelstein SI; Dunnick NR; Wilkinson RH; Bollinger RR; McCann RL; Beytas EM; Klotman PE
    Hypertension; 1989 Sep; 14(3):247-57. PubMed ID: 2670763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.